Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Hemostasis and cerebral metastases in a model system

Gregory J. Del Zoppo, Yu-Huan Gu

Blood (2021) 137 (9): 1139–1140.

https://doi.org/10.1182/blood.2020010130

Published: 2021

Journal Articles

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model

Manuel J. Feinauer, Stefan W. Schneider, Anna S. Berghoff, Jose Ramon Robador, Cedric Tehranian, Matthia A. Karreman, Varun Venkataramani, Gergely Solecki, Julia Katharina Grosch, Katharina Gunkel, Bogdana Kovalchuk, Frank Thomas Mayer, Manuel Fischer, Michael O. Breckwoldt, Maik Brune, Yannick Schwab, Wolfgang Wick, Alexander T. Bauer, Frank Winkler

Blood (2021) 137 (9): 1219–1232.

https://doi.org/10.1182/blood.2020005710

Published: 2021

Includes: Supplemental data

Journal Articles

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Tariq Zuheir Kewan, MD, Shafia Rahman, MBBS, Fahrettin Covut, MD, Ramsha Ahmed, MD, Seba Hasan, Yihong Zhou, MD, Alok A Khorana, MD

Blood (2019) 134 (Supplement_1): 3683.

https://doi.org/10.1182/blood-2019-131758

Published: 2019

Journal Articles

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2019) 134 (Supplement_1): 2438.

https://doi.org/10.1182/blood-2019-126027

Published: 2019

Journal Articles

Safety of Doacs in Patients with CNS Malignancies

Andrew Swartz, MD, Jan Drappatz

Blood (2019) 134 (Supplement_1): 1160.

https://doi.org/10.1182/blood-2019-125161

Published: 2019

Journal Articles

Prognostic Validation of Diffuse Large B Cell Lymphoma International Prognostic Index for High Grade B Cell Lymphoma with and without MYC and BCL2 or BCL6 Rearrangements: An Institutional Review

Gowthami Kanagalingam, MD, Vrinda Vyas, MBBS, Alina Basnet, MBBS, Garry Brooks, Dr. PH, Alexandria Smith, MD

Blood (2019) 134 (Supplement_1): 5362.

https://doi.org/10.1182/blood-2019-132066

Published: 2019

Journal Articles

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2018) 132 (Supplement 1): 2521.

https://doi.org/10.1182/blood-2018-99-115666

Published: 2018

Journal Articles

Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis

Shafia Rahman, MD, Fahrettin Covut, MD, Yihong Zhou, MD, Shab E Gul Rahim, MD, Sudha Amarnath, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1242.

https://doi.org/10.1182/blood-2018-99-119686

Published: 2018

Journal Articles

The Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis

Montreh Tavakkoli, MD MA, Cy Wilkins, MD, Jodi V Mones, MD, Michael J. Mauro, MD

Blood (2018) 132 (Supplement 1): 4944.

https://doi.org/10.1182/blood-2018-99-117484

Published: 2018

Journal Articles

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Taylor Hanson, Ravi Patel, DO, Nitasa Sahu, MD, Zain Ayaz, MD, Julie Caler, Pharm.D, Kirk Jones, Pharm.D, Rohit Jain, MBBS

Blood (2018) 132 (Supplement 1): 4966.

https://doi.org/10.1182/blood-2018-99-112705

Published: 2018

Journal Articles

Case Series of Potential Wernicke's Encephalopathy in Patients Treated with Fedratinib

Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Ruben A Mesa, MD, Catriona Jamieson, MD PhD, John Hood, PhD, Julie Bykowski, MD, Giulio Zuccoli, MD, James Brewer, MD,PhD

Blood (2017) 130 (Supplement 1): 4197.

https://doi.org/10.1182/blood.V130.Suppl_1.4197.4197

Published: 2017

Journal Articles

Safety and Efficacy of Crizotinib in ALK-Positive Lymphomas: A Phase 1b Open-Label Study

Carlo Gambacorti-Passerini, MD, Sergey Orlov, Li Zhang, Fadi Braiteh, Huiqiang Huang, Taito Esaki, Keizo Horibe, Jin-Seok Ahn, Joseph T. Beck, William Jeffrey Edenfield, Yuankai Shi, Matthew Taylor, Kenji Tamura, Brian A. Van Tine, Shang-Ju Wu, MD, PhD, Jolanda Paolini, Sherry Li, Tae Min Kim

Blood (2017) 130 (Supplement 1): 4128.

https://doi.org/10.1182/blood.V130.Suppl_1.4128.4128

Published: 2017

Journal Articles

Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors

Mohana Roy, MD, Charlene Mantia, MD, Erik J Uhlmann, MD, Maneka Puligandla, MS, Griffin Weber, MD PhD, Donna S. Neuberg, ScD, Jeffrey I Zwicker, MD

Blood (2017) 130 (Supplement 1): 2388.

https://doi.org/10.1182/blood.V130.Suppl_1.2388.2388

Published: 2017

Journal Articles

Retrospective Analysis of Cancer-Associated Venous Thromboembolism in Patients with High Risk Cancer Types in Taiwan

Sheng-Chieh Chou, MD, Woei Tsai, MD, PhD, Shu-Wha Lin, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 3699.

https://doi.org/10.1182/blood.V130.Suppl_1.3699.3699

Published: 2017

Journal Articles

MET-PET and NGS Targeted Sequencing Guides Precision Medicine in a CNS Relapsed MM Patient

Matteo Da Via', MD, Susanne Strifler, MD, Santiago Barrio Garcia, PhD, Andoni Garitano Trojaola, PhD, Eva Teufel, Silvia Nerreter, A. Keith Stewart, MBChB, MBA, Andreas Rosenwald, Anke Heidemeier, MD, Constantin Lapa, MD, Hermann Einsele, K. Martin Kortüm, MD

Blood (2017) 130 (Supplement 1): 5361.

https://doi.org/10.1182/blood.V130.Suppl_1.5361.5361

Published: 2017

Journal Articles

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

Andres Forero-Torres, MD, Seth Rosen, MD, David C. Smith, MD, Glenn Lesser, MD, Julio Peguero, MD, Shilpa Gupta, MD, Justin M. Watts, MD, Marcus Noel, MD, Razelle Kurzrock, MD, Haeseong Park, MD, Patricia LoRusso, DO, Catherine C. Coombs, MD, Fred Zheng, MD, Julie Switzky, RN, Swamy Yeleswaram, PhD, Gerald Falchook, MD

Blood (2017) 130 (Supplement 1): 4048.

https://doi.org/10.1182/blood.V130.Suppl_1.4048.4048

Published: 2017

Journal Articles

The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic Leukaemia

Joshua W.D. Tobin, MD, Jane Royle, MBBS, Robert Mason, MBBS, Millward Michael, Warburton Lydia, Shahneen Sandhu, Andrew Haydon, Georgina Long, Matteo Carlino, Jessica L Smith, Helen Dearden, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Devinder Gill, MD, Sally Mapp, MD PhD, Victoria Atkinson, Colm Keane, MB, PhD

Blood (2017) 130 (Supplement 1): 5338.

https://doi.org/10.1182/blood.V130.Suppl_1.5338.5338

Published: 2017

Journal Articles

Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study

Charlene Mantia, MD, Erik Uhlmann, MD, Maneka Puligandla, MS, Donna S. Neuberg, ScD, Griffin M. Weber, MD PhD, Jeffrey I. Zwicker, MD

Blood (2016) 128 (22): 142.

https://doi.org/10.1182/blood.V128.22.142.142

Published: 2016

Journal Articles

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score

Dana E. Angelini, MD, M. Todd Greene, PhD MPH, Julie N Wietzke, MHSA, MLS, Scott A Flanders, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 1181.

https://doi.org/10.1182/blood.V128.22.1181.1181

Published: 2016

Journal Articles

Inferior Vena Cava Filter (IVCF) Placement in a Community Hospital: Adherence to Guidelines, Retrieval Rates, and Complications

Ayesha Haque, MBBS, MD, Basir Ul Haque, MDMBBS, Thomas A. Rado, MD PhD, Saravanan Kasthuri, MD, Rangaswamy Chintapatla, MD

Blood (2016) 128 (22): 5910.

https://doi.org/10.1182/blood.V128.22.5910.5910

Published: 2016

NARROW

Hemostasis and cerebral metastases in a model system

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Safety of Doacs in Patients with CNS Malignancies

Prognostic Validation of Diffuse Large B Cell Lymphoma International Prognostic Index for High Grade B Cell Lymphoma with and without MYC and BCL2 or BCL6 Rearrangements: An Institutional Review

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis

The Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Case Series of Potential Wernicke's Encephalopathy in Patients Treated with Fedratinib

Safety and Efficacy of Crizotinib in ALK-Positive Lymphomas: A Phase 1b Open-Label Study

Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors

Retrospective Analysis of Cancer-Associated Venous Thromboembolism in Patients with High Risk Cancer Types in Taiwan

MET-PET and NGS Targeted Sequencing Guides Precision Medicine in a CNS Relapsed MM Patient

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic Leukaemia

Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score

Inferior Vena Cava Filter (IVCF) Placement in a Community Hospital: Adherence to Guidelines, Retrieval Rates, and Complications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only